Doxazosin Mesylate Tablet
Product Images NDC 71610-965

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Doxazosin Mesylate (NDC 71610-965). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (71610 0965 53)

Label for Doxazosin mesylate 4 mg oral tablets, containing 60 tablets per bottle. The label includes storage instructions, manufacturer Greenstone LLC in Morgantown, WV, and packager Aphena Pharma Solutions - Tennessee, LLC in Cookeville, TN. It displays the NDC 71610-965-53 and specifies the product as prescription only.*

FDA Label Image

Aphena (Aphena)

FDA Label Image

Doxazosin Structural Formula (Image 01)

Chemical structure of doxazosin mesylate, depicting its molecular framework with the methanesulfonic acid (mesylate) component shown as a separate group.*

FDA Label Image

Table 3. (Image 02)

A data table summarizing effectiveness data from placebo-controlled trials of doxazosin mesylate, presenting symptom score and maximum flow rate mean baselines and changes for placebo and CARDURA (4 mg and 8 mg) groups across three studies. Includes notes on questionnaire types, endpoints, dosing, and statistical significance. A small adjacent bar graph illustrates maximum flow rate changes for Study 2 with placebo, 4 mg, and 8 mg doses.*

FDA Label Image

Figure 1 – Study 1 (Image 03)

Two line graphs comparing placebo and Cardura treatments over 14 weeks. The left graph shows mean change in total symptom score from baseline, with Cardura displaying a greater decrease. The right graph shows mean increase in maximum urinary flow rate (mL/sec) from baseline, with Cardura exhibiting a higher increase. Both graphs include statistical significance markers.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.